Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-019936·Corvus Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Corvus Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 221015100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Richard A. Miller
Shares: 5,220,368 · Class: 7.7%
- Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985
Shares: 1,765,737 · Class: 2.7%
- Sandra J. Horning
Shares: 1,765,737 · Class: 2.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-019936
- Form type
- SCHEDULE 13G/A
- Filer
- Corvus Pharmaceuticals, Inc.
- CIK
- CIK 1626971
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership